Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tarceva in Untreated Advanced Non-Small Cell Lung Cancer
NCT00585533Phase 2Completed
- Sponsor
- University of Utah
- Start
- Jun 2004
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib in non-small cell lung cancer (NSCLC), sponsored by University of Utah. Started Jun 2004; status: completed.
02
Drugs
erlotinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00585533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00585533.